Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to thiopental anesthesia for hemodynamic control during electroconvulsive therapy
IRCT20160307026950N13Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine and thiopental in mental disorder (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Blood pressure and Heart rate. Started Mar 2018; status: completed.
02
Drugs
dexmedetomidinethiopental
03
Conditions
mental disorder
Beyond the preview
Go deeper on IRCT20160307026950N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N13.